Longevity Health extends merger deadline with 20/20 Biolabs to July 8, 2025

Longevity Health Holdings, Inc.

Due Diligence Contingency Deadline moved to July 8, 2025; merger agreement will auto-terminate on that date unless extended in writing.
Amendment signed June 24, 2025; original Agreement and Plan of Merger dated April 11, 2025.
No other provisions of the merger agreement were modified beyond the deadline extension.
Parties: Longevity Health Holdings, Merger Sub, 20/20 Biolabs, and stockholder representative Jonathan Cohen.

item 1.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.